Literature DB >> 6190975

Protective Plasmodium knowlesi Mr 74,000 antigen in membranes of schizont-infected rhesus erythrocytes.

R Schmidt-Ullrich, J Lightholder, M T Monroe.   

Abstract

The immunogenic Plasmodium knowlesi (H strain) Mr 74,000 protein in membranes of schizont-infected rhesus erythrocytes was purified on a large scale, free of other polypeptides as monitored by dodecyl sulfate polyacrylamide gel electrophoresis and isoelectric focusing. In a limited vaccination trial, four rhesus monkeys were immunized four consecutive times with the Mr 74,000 protein and Freund's complete and incomplete adjuvants. Two monkeys were injected with adjuvant only. Upon challenge with 10(4) viable P. knowlesi schizonts of the heterologous W strain, the control monkeys developed fatal parasitemias after 7 d. In contrast, the vaccinated monkeys exhibited a delayed onset of patent parasitemias and underwent self-cure on days 14 to 16 after peak parasitemias of between 7 and 11%. The protective immunity that was induced crossed different strains of P. knowlesi. Blood smears at the time of cure demonstrated limited reinfection, as indicated by the presence of normally appearing ring and trophozoite stages. The absence of schizont stages in the peripheral blood suggested a specific interruption of the erythrocytic schizogony at that stage. Immunochemical analyses of the rhesus sera revealed antibody only against the Mr 74,000 protein after the first two immunizations. Upon repeated antigen injection, antibodies reacted with components of Mr of approximately 102,000, 140,000, and 230,000 in addition to the Mr 74,000 protein. Besides immunological cross-reactivity, relatedness between all four immune-precipitated proteins was indicated by a greater than 50% tryptic peptide homology, suggesting that the Mr 230,000 component represents a precursor protein that is cleaved within the infected erythrocyte into proteins with Mr of approximately 140,000, 102,000, and 74,000.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190975      PMCID: PMC2187067          DOI: 10.1084/jem.158.1.146

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Quantitative determination of soluble and membrane proteins through their native fluorescence.

Authors:  K Resch; W Imm; E Ferber; D F Wallach; H Fischer
Journal:  Naturwissenschaften       Date:  1971-04

Review 3.  Immunity to asexual erythrocytic stages of Plasmodium falciparum: role of defined antigens in the humoral response.

Authors:  L H Perrin; R Dayal
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

4.  A freeze-dried merozoite vaccine effective against Plasmodium knowlesi malaria.

Authors:  G H Mitchell; G A Butcher; J Langhorne; S Cohen
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

5.  Inhibitory effects of immune monkey serum on synchronized Plasmodium falciparum cultures.

Authors:  J D Chulay; M Aikawa; C Diggs; J D Haynes
Journal:  Am J Trop Med Hyg       Date:  1981-01       Impact factor: 2.345

6.  Plasmodium lophurae: immunogenicity of a histidine-rich protein.

Authors:  A Kilejian
Journal:  Exp Parasitol       Date:  1981-10       Impact factor: 2.011

7.  Simian virus 40 (SV40)-specific isoelectric point-4.7--94,000-Mr membrane glycoprotein: major peptide homology exhibited with the nuclear and membrane-associated 94,000-Mr SV40 T-antigen in hamsters.

Authors:  R Schmidt-Ullrich; W S Thompson; S J Kahn; M T Monroe; D F Wallach
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

8.  Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.

Authors:  R R Freeman; A J Trejdosiewicz; G A Cross
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

9.  Rhesus monkeys protected against Plasmodium knowlesi malaria produce antibodies against a 65,000-MrP. knowlesi glycoprotein at the surface of infected erythrocytes.

Authors:  R Schmidt-Ullrich; L H Miller; D F Wallach; J Lightholder; K G Powers; R W Gwadz
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

10.  Determinants on surface proteins of Plasmodium knowlesi merozoites common to Plasmodium falciparum schizonts.

Authors:  L H Miller; J G Johnson; R Schmidt-Ullrich; J D Haynes; D F Wallach; R Carter
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Malaria: immunity, vaccination and immunodiagnosis.

Authors:  L Perrin; A Perez; C Chizzolini
Journal:  Experientia       Date:  1984-12-15

2.  A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami.

Authors:  A M Lew; C J Langford; R F Anders; D J Kemp; A Saul; C Fardoulys; M Geysen; M Sheppard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Identification and expression in Escherichia coli of merozoite stage-specific genes of the human malarial parasite Plasmodium falciparum.

Authors:  M J McGarvey; E Sheybani; M P Loche; L Perrin; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

4.  Recent progress in the development of malaria vaccines: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

Review 5.  Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function.

Authors:  Owain R Millington; Caterina Di Lorenzo; R Stephen Phillips; Paul Garside; James M Brewer
Journal:  J Biol       Date:  2006-04-12

6.  Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages.

Authors:  L H Perrin; B Merkli; M Loche; C Chizzolini; J Smart; R Richle
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

7.  Human-human hybridomas secreting monoclonal antibodies to the Mr 195,000 Plasmodium falciparum blood stage antigen.

Authors:  R Schmidt-Ullrich; J Brown; H Whittle; P S Lin
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

8.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.

Authors:  H Perlmann; K Berzins; M Wahlgren; J Carlsson; A Björkman; M E Patarroyo; P Perlmann
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.